Most of the antibiotics in use today are derivatives of natural products of actinomycetes and fungi \[[@B1]\]. Antibiotics produced by actinomycetes and other microbes have been evolving for one billion years \[[@B2]\] and their activity has been tested against microbes based on their ability to inhibit target enzymes and macromolecules. Actinomycetes can be isolated from soil and marine environments. Since collecting soil is relatively inexpensive, much is known about the distribution and abundance of terrestrial actinomycetes. Although soils have been screened by the pharmaceutical industry for the past five decades, only a small fraction of actinomycetes have been discovered \[[@B2]\]. Actinomycetes from unexplored habitats have gained considerable attention in recent years for the production of bioactive metabolites. The list of novel actinomycetes and products derived from poorly explored areas of the world stresses the importance of investigating new habitats \[[@B3]\]. Members of marine actinomycetes particularly found in mangrove habitats have been poorly studied \[[@B4]\].

Mangroves are unique woody plant communities of intertidal coasts in tropical and subtropical regions and are highly productive ecosystems \[[@B5]\]. Although surprisingly little is known about the microbial communities present there \[[@B6]\], there is evidence that mangrove sediments contain high populations of novel actinomycetes, as illustrated by the isolation of *Asanoa iriomotensis* \[[@B7]\] and *Nonomuraea maheshkhaliensis* \[[@B8]\]. The most promising source of future antibiotics consists of natural microbial products \[[@B9]\]. The requirement for discovery and isolation of novel chemical structures from unique untapped niches is undisputed. This is achieved by investigating new microbial sources for production of antimicrobial agents from non-*Streptomyces* actinomycetes \[[@B10]\].

In a screening program designed to discover antimicrobial compounds from rare actinomycetes, *Pseudonocardia* sp. VUK-10 was isolated from soil sediments of Nizampatnam mangrove ecosystem. The bioactive metabolite profile of *Pseudonocardia* spp. includes antibacterial, antifungal, enzyme inhibitors, neuroprotective and anti-*Helicobacter pylori* compounds. A new phenazine derivative from *Pseudonocardia* sp. B6273, i.e., phenazostatin D, acts as a neuroprotective substance \[[@B11]\]. Omura et al. \[[@B12]\] reported antimicrobial activity of azureomycins A and B extracted from *P. azurea*. Dekker et al. \[[@B13]\] extracted new quinolone compounds from *Pseudonocardia* sp. with selective and potent anti-*Helicobacter pylori* activity. The ability of strains to form antimicrobial substances can be significantly influenced by different conditions of nutrition and cultivation. Therefore, the medium constitution together with the metabolic capacity of the producing microorganism greatly affects synthesis of bioactive metabolites. Several environmental factors, such as temperature, pH, and incubation period, play a major role in the production of antimicrobial agents \[[@B14]\]. In this study, we tried to optimize the cultural conditions of the isolate *Pseudonocardia* sp. and facilitate improved production of biologically active compounds.

Materials and Methods
=====================

*Pseudonocardia* sp. VUK-10 was isolated from soil sediments of \"Nizampatnam Mangrove Ecosystem\" of south coastal Andhra Pradesh, India, by using the soil dilution plate technique on asparagine-glucose agar medium with pH 7.2 \[[@B15]\]. The pure cultures were maintained on yeast extract-malt extract-dextrose (YMD; ISP-2) agar medium at 4℃. The strain has been deposited in the NCBI GenBank with the accession No. JN087501. The test organisms used in the present study were procured from ATCC, University Boulevard, Manassas, USA and MTCC, IMTECH, Chandigarh, India and preserved at 4℃.

Growth pattern and antimicrobial profile
----------------------------------------

The growth pattern and antimicrobial profile of *Pseudonocardia* sp. was studied at regular intervals for up to 7 days. The strain was cultured for one wk and then transferred aseptically into the seed medium (asparagine-glucose broth) and incubated for 48 hr. 10% of the 24-hr-old seed culture was inoculated into the production medium of the same composition. Fermentation was carried out at 28 ± 2℃ for 7 days, under centrifugation at 120 rpm. The culture broth was harvested at 24 hr intervals and biomass was expressed as mg/100 mL. The culture filtrate thus collected was extracted with ethyl acetate and evaporated to dryness in a water bath at 80℃ \[[@B16]\]. The production of bioactive metabolites was assessed by measuring the diameter of the inhibition zone against Gram positive bacteria - *Staphylococcus aureus* (MTCC 497), *Bacillus subtilis* (MTCC 3160) and *Streptococcus mutans* (MTCC 497) and Gram negative bacteria - *Escherichia coli* (ATCC 35218) and *Pseudomonas aeruginosa* (ATCC 9027), as well as *Candida albicans* (ATCC 10231).

Selection of the culture media on biomass and bioactive metabolite production
-----------------------------------------------------------------------------

To select the suitable growth medium, the isolate actynomicete was grown in 11 different culture media, such as starch-casein broth, tyrosine broth (ISP-7), glycerol-asparagine broth, starch inorganic salts broth (ISP-4), yeast-starch broth, malt extract broth, modified YMD broth (ISP-2), tryptone-yeast extract broth (ISP-1), maltose tryptone broth, soya bean meal broth and Czapek-Dox broth \[[@B17]\]. The biomass accumulation and bioactive metabolite production for the media were determined after 4th day of incubation. The medium in which the strain exhibited maximum antibiotic production expressed in terms of zone of inhibition was used as the optimized medium for further study.

Effects of supplementary carbon and nitrogen sources on biomass and bioactive metabolite production
---------------------------------------------------------------------------------------------------

Carbon sources such as maltose, lactose, fructose, galactose, sucrose, glucose, starch, mannitol, arabinose, xylose, glycerol, and raffinose 1% were supplemented separately into the fermentation medium. The effect of varying concentrations (0.5\~5%) of the best carbon source on the growth and bioactive metabolite production was also investigated. Similarly, various nitrogen sources, such as sodium nitrate, ammonium sulfate, ammonium oxalate, peptone, tryptone, casein, lysine, asparagine, arginine, glutamine, and tyrosine 0.5% were individually supplemented into the fermentation medium \[[@B18]\]. Further, the impact of different levels (0.1\~2%) of optimized nitrogen source was studied to enhance antimicrobial metabolite production \[[@B19]\].

Effects of minerals on biomass and bioactive metabolite production
------------------------------------------------------------------

To evaluate the effects of minerals on the growth and bioactive metabolite production, the optimized medium with superior carbon and nitrogen sources was treated separately with different minerals, such as KH~2~PO~4~, MgSO~4~, FeSO~4~, K~2~HPO~4~, and ZnSO~4~, each at a concentration of 0.05% (w/v) \[[@B20]\].

Effects of initial pH and incubation temperature on biomass and bioactive metabolite production
-----------------------------------------------------------------------------------------------

The initial pH levels of the growth media were adjusted from 4 to 10, to study the impact of pH. The biomass and bioactive metabolite production were estimated and the optimum pH achieved for maximum bioactive metabolite production was used for subsequent study \[[@B21]\]. Similarly, the optimum temperature for cell growth and bioactive metabolite yield was measured by incubating the production medium at temperatures ranging from 20℃ to 60℃, while maintaining all other conditions at optimum levels \[[@B22]\].

Test organisms
--------------

The antimicrobial metabolites of the strain produced under optimized conditions were tested by the agar-diffusion assay against several bacteria, including *Streptococcus mutans* (MTCC 497), *Lactobacillus casei* (MTCC 1423), *Lactobacillus acidophilus* (MTCC 495). *Enterococcus faecalis* (MTCC 439), *Staphylococcus aureus* (MTCC 3160), *Bacillus subtilis* (ATCC 6633), *Escherichia coli* (ATCC 35218), *Pseudomonas aeruginosa* (ATCC 9027), *Proteus vulgaris* (MTCC 7299), *Shigella flexneri* (MTCC 1457) and *Xanthomonas campestris* (MTCC 2286), and fungi, such as *Candida albicans* (ATCC 10231), *Aspergillus niger*, *Aspergillus flavus*, *Fusarium oxysporum* (MTCC 3075), and *Penicillum citrinum*.

Results and Discussion
======================

Growth pattern and antimicrobial profile
----------------------------------------

The stationary phase of *Pseudonocardia* sp. VUK-10 extended from 72 hr to 120 hr of incubation. The bioactive metabolites obtained from 4-day-old culture exhibited high antimicrobial activity against the test microorganisms ([Fig. 1](#F1){ref-type="fig"}). Sujatha et al. \[[@B23]\] reported that metabolites elaborated from 4-day-old culture of *Streptomyces psammoticus* showed good antimicrobial activity against methicillin resistant *Staphylococcus aureus*. Similarly, metabolites collected from 4-day-old culture of *Nocardia levis* MK_VL113 also exhibited good antimicrobial activity \[[@B24]\].

Selection of culture media suitable for biomass and bioactive metabolite production
-----------------------------------------------------------------------------------

The influence of different media on the production of biomass and bioactive metabolites was recorded ([Fig. 2](#F2){ref-type="fig"}). Among the tested media, modified YMD broth increased bioactive metabolites, followed by maltose-tryptone broth and Czapek-Dox broth, whereas the production of biomass was high in Soya bean meal broth, followed by Starch inorganic salts broth and modified YMD (ISP-2) broth. Oskay \[[@B21]\] showed that the activity of actinomycete isolates could be increased or decreased remarkably under different cultural conditions. Similarly, Thakur et al. \[[@B17]\] reported that Thornton\'s medium increased biomass and bioactive metabolite production of *Streptomyces* sp. 201.

Effects of supplementary carbon and nitrogen sources on biomass and bioactive metabolite production
---------------------------------------------------------------------------------------------------

In order to design the effective medium, the roles of different carbon and nitrogen sources were evaluated for their impact on growth and bioactive metabolite production ([Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Among the various carbon sources tested, glucose was the best carbon source for both biomass and bioactive metabolite production. This result is comparable with that from a previous study \[[@B25]\], showing that *Streptomyces sannanensis* strain RJT-1 utilized glucose as the sole carbon source for antibiotic production. Similarly, Cruz et al. \[[@B26]\] reported that the antibiotic production of *S. griseocarneus* was increased by glucose.

As glucose was the most preferred carbon source for biomass and bioactive metabolite production by the strain, different levels of glucose (0.5\~5%) were tested to determine optimal concentration for bioactive metabolite production ([Fig. 5](#F5){ref-type="fig"}). Two percentage glucose supplemented in the medium promoted the highest biomass production, whereas 1% glucose was found to be the best for bioactive metabolite production. Earlier reports also suggested that antibiotic production was observed when glucose at 1% concentration was used as sole source of carbon \[[@B27], [@B28]\].

Different nitrogen sources were found to have significant effects on growth and secondary metabolite production by *Pseudonocardia* sp. VUK-10. Maximum antimicrobial activity was obtained in culture filtrates supplemented with tryptone, followed by tyrosine and asparagine, whereas the biomass production was found to be increased with tyrosine ([Fig. 6](#F6){ref-type="fig"}). Similar results were obtained with *Nocardia levis* MK_VL113, as reported by Kavitha and Vijayalakshmi \[[@B24]\]. Atta et al. \[[@B29]\] showed that optimal antimicrobial activity was obtained with 0.25% sodium nitrate in the culture medium of *Streptomyces albidoflavus* 143.

Effects of minerals on biomass and bioactive metabolite production
------------------------------------------------------------------

The impact of minerals on biomass and bioactive metabolite production of the investigated strain is represented in [Fig. 7](#F7){ref-type="fig"}. K~2~HPO~4~ enhanced the production of cell mass and bioactive metabolites. In contrast, the production of bioactive metabolites was very low with ZnSO~4~ and FeSO~4~. Majumdar and Majumdar \[[@B30]\] reported maximum yield of neomycin by *Streptomyces fradiae* with K~2~HPO~4~ and least with ZnSO~4~. Similar results have been recorded by Ripa et al. \[[@B22]\] and Narayana and Vijayalakshmi \[[@B20]\].

Effects of initial pH and incubation temperature on biomass and bioactive metabolite production
-----------------------------------------------------------------------------------------------

The environmental requirements and cultural conditions for growth and bioactive metabolite production have been studied. Maximum growth, as well as increased antimicrobial metabolites, were obtained at pH 7 ([Fig. 8](#F8){ref-type="fig"}), suggesting the neutrophilic characteristics of the strain. Similar results have been reported for several *Streptomyces* sp. \[[@B29]\].

The influence of temperature on the biomass and bioactive metabolite production of the strain is presented in [Fig. 9](#F9){ref-type="fig"}. Highest growth, as well as anti-microbial compound production, was obtained at 35℃. In terms of its optimum temperature for growth, the organism appeared to be mesophilic. These results are in complete accordance with those reported by Narayana and Vijayalakshmi \[[@B20]\].

The results obtained in the present investigation revealed that both the growth and bioactive metabolite production by *Pseudonocardia* sp. VUK-10 were mainly influenced by several environmental and cultural conditions. The optimum conditions for *in vitro* production of antimicrobial metabolites could be achieved in medium supplemented with glucose at 10 g/L as carbon source, and tryptone at 2.5 g/L as nitrogen source. Four days of incubation at 35℃ and pH 7 were found to be optimum for bioactive metabolite production ([Table 1](#T1){ref-type="table"}).

In the present study, optimal conditions for the production of bioactive metabolites by *Pseudonocardia* sp. VUK-10 were determined, and metabolites showed good antimicrobial activity against Gram positive and Gram negative bacteria, as well as unicellular and filamentous fungi. Hence, further studies on purification, characterization and identification of bioactive metabolites of *Pseudonocardia* VUK-10 are in progress. This is the first report on the optimization of bioactive metabolites produced by *Pseudonocardia* sp. VUK-10.
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